 1.7. Any recent or current systemic therapy with an antibiotic or drug with potential anti-malarial activity chloroquine, doxycycline, tetracycline, piperaquine, benzodiazepine, flunarizine, fluoxetine, tetracycline, azithromycin, clindamycin, erythromycin, hydroxychloroquine, etc. allowable timeframe for use at the Investigators discretion. 